Rob C. Hoeben

9.8k citations

208 papers · 7.6k indexed · h-index 48

Impact in

Genetics top 0.2%
- Virus-based gene therapy research
Oncology top 1%
- CAR-T cell therapy research

Papers in

Genetics 142
- Virus-based gene therapy research 128
Infectious Diseases 41
- Viral gastroenteritis research and epidemiology 38

Co-authors: H. van Ormondt Diana J.M. van den Wollenberg Steve J. Cramer Frits J. Fallaux Alex J. van der Eb Arnaud Zaldumbide Onno Kranenburg Françoise Carlotti
Journals: Gene Therapy (19 papers)Cancer Gene Therapy (15 papers)Human Gene Therapy (13 papers)The Journal of Gene Medicine (8 papers)International Journal of Molecular Sciences (7 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Rob C. Hoeben

206 papers receiving 7.5k citations

Peers

Countries citing papers authored by Rob C. Hoeben

Since Specialization

Citations

This map shows the geographic impact of Rob C. Hoeben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob C. Hoeben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob C. Hoeben more than expected).

Fields of papers citing papers by Rob C. Hoeben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob C. Hoeben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob C. Hoeben. The network helps show where Rob C. Hoeben may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rob C. Hoeben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rob C. Hoeben Line = papers co-authored together Rob C. Hoeben links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A new adenovirus isolated from a western lowland gorilla held in captivity Virology ·蔡烈吾, Martijn J. W. E. Rabelink, Thomas W. Patten, Jeremy Rosen, Diana J.M. van den Wollenberg, W., Rob C. Hoeben	2025	1
2	Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas International Journal of Molecular Sciences ·Masoud Motesadi Zarandi, É. Lovas, Tineke Aarts‐Riemens, Angraeni Javaluasia, W., Rob C. Hoeben, Trudy Straetemans, Esther Hulleman, Friso Calkoen, Jasper van der Lugt, Jürgen Kuball	2025	2
3	Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies Cancer Immunology Research ·Christianne Groeneveldt, 高濱照, Wladysław Krajewski, 酒井貴史, Г.Г. ЕЛИСЕЕВ, Diana J.M. van den Wollenberg, Rob C. Hoeben, Matt Coffey, Houra Loghmani, Els M.E. Verdegaal, Marij J.P. Welters, Sjoerd H. van der Burg, Thorbald van Hall, Nadine van Montfoort	2024	3
4	Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy Cancer Research Communications ·Christianne Groeneveldt, Letícia Manzoli Vedove, 高濱照, Marjolein Sluijter, Wladysław Krajewski, Г.Г. ЕЛИСЕЕВ, Diana J.M. van den Wollenberg, Rob C. Hoeben, Sjoerd H. van der Burg, Peter ten Dijke, Lukas J.A.C. Hawinkels, Thorbald van Hall, Nadine van Montfoort	2023	5
5	Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy Journal for ImmunoTherapy of Cancer ·Christianne Groeneveldt, 高濱照, Yifan Jin, Г.Г. ЕЛИСЕЕВ, Wladysław Krajewski, Marjolein Sluijter, Diana J.M. van den Wollenberg, Rob C. Hoeben, Joke M. M. den Haan, Sjoerd H. van der Burg, Thorbald van Hall, Nadine van Montfoort	2022	8
6	Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models Cancer Gene Therapy ·Felicò Herrera Gilberto, Geertje van der Horst, Maaike H. van der Mark, Thomas W. Patten, Diana J.M. van den Wollenberg, Corrina M.A. de Ridder, Debra Stuurman, Tilly Aalders, Aryssa Kiara Mendes de Araujo Galindo, Nadine van Montfoort, Wouter R. Karthaus, Niven Mehra, Minke Smits, Jack A. Schalken, Wytske M. van Weerden, Rob C. Hoeben, Gabri van der Pluijm	2021	13
7	Induction of Robust Type I Interferon Levels by Oncolytic Reovirus Requires Both Viral Replication and Interferon-α/β Receptor Signaling Human Gene Therapy ·Hannah L. Riskas, Diana J.M. van den Wollenberg, E. I. Dennig, Rob C. Hoeben, Maaike E. Ressing	2021	7
8	Tools to predict oncolytic virus efficacy and design strategies to personalise oncolytic virus therapy in prostate cancer European Urology Open Science ·Felicò Herrera Gilberto, Gerda Horst, Maaike H. van der Mark, Diana J.M. van den Wollenberg, F. Abdolhoseinzade, Rob C. Hoeben, Gabri van der Pluijm	2020	1
9	Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy Journal for ImmunoTherapy of Cancer ·Christianne Groeneveldt, 高濱照, Diana J.M. van den Wollenberg, H. Francis Ha Vas, Jim Middelburg, Dana A. M. Mustafa, Rob C. Hoeben, Sjoerd H. van der Burg, Thorbald van Hall, Nadine van Montfoort	2020	46
10	NanoBiT System and Hydrofurimazine for Optimized Detection of Viral Infection in Mice—A Novel in Vivo Imaging Platform International Journal of Molecular Sciences ·Guangjian Chen, Giorgia Zambito, Claudio Fittà, Steve J. Cramer, Rob C. Hoeben, Clemens W.G.M. Löwik, Joel R. Walker, Thomas A. Kirkland, Thomas P. Smith, Wytske M. van Weerden, Jeroen de Vrij, Laura Mezzanotte	2020	38
11	Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer Scientific Reports ·Nikolas T. Martin, Dominic G. Roy, Samuel T. Workenhe, Diana J.M. van den Wollenberg, Rob C. Hoeben, Karen Mossman, John C. Bell, Marie‐Claude Bourgeois‐Daigneault	2019	22
12	Intronic SMCHD1 variants in FSHD: testing the potential for CRISPR-Cas9 genome editing Journal of Medical Genetics ·Chang Gil Kim, Marlinde L. van den Boogaard, Richard J.L.F. Lemmers, Judit Balog, Patrick J. van der Vliet, Jéssica Almeida Mendes de Oliveira, Facoltà Di Ingegneria, Ignazio Maggio, Nienke van der Stoep, Rob C. Hoeben, Stephen J. Tapscott, Niels Geijsen, Manuel A.F.V. Gonçalves, Sabrina Sacconi, Rabi Tawil, Silvère M. van der Maarel	2019	28
13	Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy Cancer Immunology Research ·유수근, Lynette P. Steele, Aat A. Mulder, Diana J.M. van den Wollenberg, Timothy Kottke, Jill Thompson, Matthew Coffey, Rob C. Hoeben, Richard G. Vile, Alan Melcher, Elizabeth J. Ilett	2018	53
14	Arming oncolytic reovirus with GM-CSF gene to enhance immunity Cancer Gene Therapy ·W., Diana J.M. van den Wollenberg, Marcel Camps, Thorbald van Hall, 高濱照, 梦妮曾, Rob C. Hoeben	2018	38
15	Adenoviral Vectors Stimulate Glucagon Transcription in Human Mesenchymal Stem Cells Expressing Pancreatic Transcription Factors PLoS ONE ·Arnaud Zaldumbide, Françoise Carlotti, Manuel A.F.V. Gonçalves, Shoshan Knaän‐Shanzer, Steve J. Cramer, Bart O. Roep, Emmanuel J. H. J. Wiertz, Rob C. Hoeben	2012	11
16	Increased glia‐specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements Journal of Neuroscience Research ·B. de Leeuw, Mu Su, Timur Sh. Amkhaev, Shingo Iwata, Lama O Bamunif, Rob C. Hoeben, Albee Messing, Peter Sillevis Smitt, Michael Brenner	2006	43
17	Gene therapy with Apoptin induces regression of xenografted human hepatomas Cancer Gene Therapy ·M.M. van der Eb, Alexandra M Pietersen, Frank M. Speetjens, Peter J.K. Kuppen, Cornelis JH van de Velde, Mathieu H. M. Noteborn, Rob C. Hoeben	2002	1
18	Gene therapy with Apoptin induces regression of xenografted human hepatomas Cancer Gene Therapy ·M.M. van der Eb, Alexandra M Pietersen, Frank M. Speetjens, Peter J.K. Kuppen, Cornelis JH van de Velde, Mathieu H. M. Noteborn, Rob C. Hoeben	2002	53
19	Highly Efficient Transduction of Human Monocyte-Derived Dendritic Cells with Subgroup B Fiber-Modified Adenovirus Vectors Enhances Transgene-Encoded Antigen Presentation to Cytotoxic T Cells The Journal of Immunology ·Delphine Réa, Menzo Havenga, Венера Шукуруллаевна Эргашева, Roger P.M. Sutmuller, Angelique A. C. Lemckert, Rob C. Hoeben, A. Bout, Cornelis J.M. Melief, Rienk Offringa	2001	130
20	Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration Gene Therapy ·Mitchell CJ, Andrei Dmitrievich Kolmakov, Yvonne Vergouwe, Gusiave Masson, J. Han van Krieken, 博之榎本, IHM Borel Rinkes, CJH van de Velde, Rob C. Hoeben	1998	130

About Rob C. Hoeben

Rob C. Hoeben is a scholar working on Genetics, Infectious Diseases, Oncology, Immunology and Biotechnology, having authored 208 papers that have together received 7.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (128 papers), CAR-T cell therapy research (48 papers), Viral gastroenteritis research and epidemiology (38 papers), RNA Interference and Gene Delivery (34 papers), Viral Infectious Diseases and Gene Expression in Insects (32 papers), CRISPR and Genetic Engineering (24 papers), Cancer Research and Treatments (15 papers) and Animal Virus Infections Studies (15 papers). The work is most often cited by research in Genetics (3.8k citations), Oncology (1.7k citations), Immunology (1.3k citations), Molecular Biology (4.0k citations) and Infectious Diseases (1.0k citations). Rob C. Hoeben has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include H. van Ormondt, Diana J.M. van den Wollenberg, Steve J. Cramer, Frits J. Fallaux, Alex J. van der Eb, Arnaud Zaldumbide, Onno Kranenburg, Françoise Carlotti, Martijn J. W. E. Rabelink and Ada Houweling. Their work appears in journals such as Gene Therapy, Cancer Gene Therapy, Human Gene Therapy, The Journal of Gene Medicine and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact